Építés alatt – nem éles oldal
Belépés

NCT06788054Csak meghívásos

Intradialysis Exercise Functional Capacity, Body Composition and Survival in Hemodialysis Patients

Effect of a 12-week Intradialysis Exercise Program on Functional Capacity, Body Composition and Survival in Hemodialysis Patients: a Randomized Clinical Trial

Forrás: ClinicalTrials.gov · Utoljára frissítve: 2025. jan. 22. · Több mint 12 hónapja nem frissült - kérdezd meg a helyszínt, nyitott-e még

Következő lépések

Rövid összefoglaló (regiszter, angolul)

Chronic kidney disease and renal replacement treatments (hemodialysis, peritoneal dialysis, kidney transplant) produce various alterations at the level of muscle, bones, fat content and the heart; can alter physical capabilities such as muscle strength, resistance to climb a step repeatedly intensely, and the ability to move the joints freely, in addition to producing an increase or decrease in weight and alterations in its distribution (for example, decreasing muscle and increase fat). The above, added to the particular factors of hemodialysis such as the reduction in daily time to exercise due to the sessions, or the fatigue after it, can together generate greater repercussions on functional capacity and thus increase the risk of suffering from cardiovascular problems. and accelerate the evolution of the disease. Therefore, this study aims to determine the effect of a 12-week supervised physical exercise program during hemodialysis on strength and ability to move, the amount of fat and muscle in the body, as well as bone wear. ; and compare these results with a group of patients who do not perform supervised exercise. In addition, it will be determined how exercise can act in the long term, preventing the risk of hospitalization and death due to cardiovascular causes. The above is useful in order to establish recommendations and protocols that help us increase the quality of life and survival of the person.

Állapot (regiszter)
Csak meghívásos
Vizsgálattípus
Beavatkozással járó
Résztvevők száma
50 (tervezett)
Első benyújtás
2025. jan. 3.
Kezdés
2025. jan. 20.
Elsődleges befejezés
2025. aug. 30.
Fő szponzor
Universidad de Guanajuato
NCT-szám
NCT06788054

Mit vállalsz

  • Vizsgálat típusa: Beavatkozással járó
  • Tervezett résztvevők: 50
  • 2025. jan. 20. és az elsődleges befejezés (2025. aug. 30.) között
  • 1 helyszín, 1 országban
  • Vizitek és vizsgálatok: kérdezd a vizsgálat csapatát, a regiszter nem sorolja fel őket

A(z) ClinicalTrials.gov regisztermezőiből összeállítva. A vizsgálat felépítését írja le.

Ki nem vehet részt

Szó szerint a(z) ClinicalTrials.gov forrásból, témák szerint csoportosítva. Hogy ki vehet részt, azt csak a vizsgálat csapata dönti el.

Korábbi kezelés

  • Patients who receive a kidney transplant during the development of the exercise protocol or follow-up during the 8-month follow-up period.

Más betegség

  • If the patient presents any disease, or neurological, respiratory or skeletal muscle disorder during the development of the physical capacity tests, or during the execution of the protocol, which is aggravated by the practice of physical exercise.

Egyéb

  • When the patient voluntarily decides to leave the study.
  • When the patient begins additional strength or aerobic training.
  • Patients who decide to belong to the group that will perform intradialytic exercise.
  • When for any reason the exercise is suspended for more than three continuous times.

Kiket keres a vizsgálat

  • Male and female patients aged between 18-50 years.
  • Patients who receive regular hemodialysis sessions 3 times a week, reported through the clinical record.
  • Patients with a clinical history of being treated with HD for at least 1 previous year (reported by clinical record).
  • Patients without a history of myocardial infarction in the last 3 months (reported by clinical record).
  • Patients who are not in a kidney transplant protocol to be performed during the next 12 months.
  • Patients who have permission from their nephrology specialist to participate.
  • Patients who agree to participate in the study, and who voluntarily sign the informed consent (IC) form.
  • Patients without a history of coronary artery disease in the last 4 months (reported by clinical record).
  • Patients without myocardial instability (angina, decompensated congestive heart failure, severe arteriovenous stenosis, uncontrolled arrhythmias), reported by clinical record.
  • Patients without active infectious process (reported by clinical record).
  • Patients without extreme changes in blood glucose levels (hyperglycemia or hypoglycemia), reported by clinical record.
  • Patients without neurological, respiratory or skeletal muscle diseases or disorders that are aggravated by exercise (reported by clinical record).
  • Patients without inability to sit, stand or walk without assistance (walking device such as cane or walker is allowed) self-reported.
  • Patients without severe anemia (Hb < 8.0 g/dL), reported by clinical record.
  • Female patients should not be under sex hormone treatment or hormone replacement therapy for menopause (self-reported).
  • Patients without lupus erythematosus as the etiology of CKD, reported by clinical record.
  • Physically inactive (Do not perform physical exercise of more than 150 minutes per week on a regular basis according to data from the World Health Organization).
  • Patients who do not have amputations of any of the extremities.

Életkor a regiszterben: 18 év – 50 év · Nem: nők és férfiak · Egészséges önkénteseket nem fogad

A teljes feltétellista: ClinicalTrials.gov

Helyszínek (1)

Helyszínek a regiszter sorrendjében. Ha a profilodba mented a városodat, távolság szerint rendeződnek.

HelyszínVárosOrszágHelyszín állapota
Departamento de Ciencias Médicas Universidad de GuanajuatoLeónMexikóIsmeretlen állapot

Te vagy a koordinátor? Erősítsd meg az adatokat

Ez az oldal tájékoztatás, nem orvosi tanács. Bármely vizsgálatról az orvosoddal beszélj.